Retraction. Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab

Br J Cancer. 2012 Dec 4;107(12):2024. doi: 10.1038/bjc.2012.497.
No abstract available

Publication types

  • Retraction of Publication